Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Revolution Medicines, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 31,514 shares of RVMD stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,514Holding current value
$1.35 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
278Shares Held
161MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA14.9MShares$640 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$576 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$490 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$486 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$325 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.77B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...